首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer
Authors:Rodina Anna  Vilenchik Maria  Moulick Kamalika  Aguirre Julia  Kim Joungnam  Chiang Anne  Litz Julie  Clement Cristina C  Kang Yanlong  She Yuhong  Wu Nian  Felts Sara  Wipf Peter  Massague Joan  Jiang Xuejun  Brodsky Jeffrey L  Krystal Geoffrey W  Chiosis Gabriela
Institution:Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA.
Abstract:The heat shock protein 90 (Hsp90) has a critical role in malignant transformation. Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood. By using selective compounds, we have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90. Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled. These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号